These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 17653291)

  • 61. N,N-dimethyl-2-(2-amino-4-(18)F-fluorophenylthio)-benzylamine (4-(18)F-ADAM): an improved PET radioligand for serotonin transporters.
    Shiue GG; Choi SR; Fang P; Hou C; Acton PD; Cardi C; Saffer JR; Greenberg JH; Karp JS; Kung HF; Shiue CY
    J Nucl Med; 2003 Dec; 44(12):1890-7. PubMed ID: 14660713
    [TBL] [Abstract][Full Text] [Related]  

  • 62. FlipADAM: a potential new SPECT imaging agent for the serotonin transporter.
    Wang JL; Deutsch EC; Oya S; Kung HF
    Nucl Med Biol; 2010 Jul; 37(5):577-86. PubMed ID: 20610162
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Low brain serotonin transporter binding in major depressive disorder.
    Newberg AB; Amsterdam JD; Wintering N; Shults J
    Psychiatry Res; 2012 May; 202(2):161-7. PubMed ID: 22698760
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Evaluation of reference tissue model and tissue ratio method for 5-HTT using [(123)I] ADAM tracer.
    Yang BH; Wang SJ; Chou YH; Su TP; Chen SP; Lee JS; Chen JC
    Comput Methods Programs Biomed; 2008 Dec; 92(3):294-8. PubMed ID: 18440664
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Revisiting an old issue: the discrepancy between tissue ratio-derived binding parameters and kinetic modeling-derived parameters after a bolus of the serotonin transporter radioligand 123I-ADAM.
    Slifstein M
    J Nucl Med; 2008 Feb; 49(2):176-8. PubMed ID: 18245741
    [No Abstract]   [Full Text] [Related]  

  • 66. Addition of methylphenidate to intensive dialectical behaviour therapy for patients suffering from comorbid borderline personality disorder and ADHD: a naturalistic study.
    Prada P; Nicastro R; Zimmermann J; Hasler R; Aubry JM; Perroud N
    Atten Defic Hyperact Disord; 2015 Sep; 7(3):199-209. PubMed ID: 25634471
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Association between serotonin transporter availability and overall rating scores of quality of life in healthy volunteers.
    Tsai HC; Yeh TL; Hsieh MH; Lee IH; Chen KC; Chen PS; Yang YK; Yao WJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Jun; 33(4):711-4. PubMed ID: 19332100
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Biodistribution study of [(123)I] ADAM in mice: correlation with whole body autoradiography.
    Lin KJ; Ye XX; Yen TC; Wey SP; Tzen KY; Ting G; Hwang JJ
    Nucl Med Biol; 2002 Aug; 29(6):643-50. PubMed ID: 12234588
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The degree of depression in Hamilton rating scale is correlated with the density of presynaptic serotonin transporters in 23 patients with Wilson's disease.
    Eggers B; Hermann W; Barthel H; Sabri O; Wagner A; Hesse S
    J Neurol; 2003 May; 250(5):576-80. PubMed ID: 12736737
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Dysregulation of regional endogenous opioid function in borderline personality disorder.
    Prossin AR; Love TM; Koeppe RA; Zubieta JK; Silk KR
    Am J Psychiatry; 2010 Aug; 167(8):925-33. PubMed ID: 20439388
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Development of acute and subacute toxicity with the serotonin transporter radiopharmaceutical, ADAM.
    Chang KW; Chen CC; Lee SY; Shen LH; Wang HE
    Drug Chem Toxicol; 2010 Oct; 33(4):393-402. PubMed ID: 20550426
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Enhanced intensity dependence as a marker of low serotonergic neurotransmission in borderline personality disorder.
    Norra C; Mrazek M; Tuchtenhagen F; Gobbelé R; Buchner H; Sass H; Herpertz SC
    J Psychiatr Res; 2003; 37(1):23-33. PubMed ID: 12482467
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Borderline personality disorder and its symptom clusters: A review of positron emission tomography and single photon emission computed tomography studies.
    Karas KH; Baharikhoob P; Kolla NJ
    Psychiatry Res Neuroimaging; 2021 Oct; 316():111357. PubMed ID: 34488007
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Functional evaluation using multistep registration with standard magnetic resonance and ADAM brain images.
    Huang CI; Sun YN; Yao WJ
    Nucl Med Commun; 2011 Jul; 32(7):635-40. PubMed ID: 21540756
    [TBL] [Abstract][Full Text] [Related]  

  • 75. New methods for registering long-time I-123 ADAM SPECT image sequences to magnetic resonance images.
    Huang CI; Yao WJ; Sun YN
    Nucl Med Commun; 2010 Aug; 31(8):734-40. PubMed ID: 20505552
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Impaired platelet [3H]paroxetine binding in female patients with borderline personality disorder.
    Ng Ying Kin NM; Paris J; Schwartz G; Zweig-Frank H; Steiger H; Nair NP
    Psychopharmacology (Berl); 2005 Nov; 182(3):447-51. PubMed ID: 16052363
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Patterns of altered regional brain glucose metabolism in borderline personality disorder and bipolar II disorder.
    Bøen E; Hjørnevik T; Hummelen B; Elvsåshagen T; Moberget T; Holtedahl JE; Babovic A; Hol PK; Karterud S; Malt UF
    Acta Psychiatr Scand; 2019 Mar; 139(3):256-268. PubMed ID: 30552759
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The correlation between mid-brain serotonin transporter availability and intelligence quotient in healthy volunteers.
    Tseng PY; Lee IH; Chen KC; Chen PS; Chiu NT; Yao WJ; Chu CL; Yeh TL; Yang YK
    Eur Psychiatry; 2015 Feb; 30(2):193-7. PubMed ID: 25447350
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Personality Disorders and Development.
    Möhler E
    Brain Sci; 2022 Jul; 12(8):. PubMed ID: 35892424
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.